Gilead Sciences
Nasdaq GILD · Foster City, CA
Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Gilead Sciences is a clinical trial sponsor based in Foster City, CA, listed as Nasdaq GILD. It has 67 active clinical trials with 31,800 planned participants, across 14 therapeutic areas. Since 2021 it has completed 96 trials and stopped 69 early.
Trial track record · since 2021
Financials · Nasdaq GILD
Fundraising
Pipeline · 67 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
27 approved drug applications with a product on the market.
Questions about Gilead Sciences
Gilead Sciences is lead sponsor of 67 active clinical trials on ClinicalTrials.gov, with 31,800 planned participants, in Cardiovascular, Dermatology, Genetic & rare, GI & liver and other areas. Since 2021 it has completed 96 trials and stopped 69 early.
Gilead Sciences is based in Foster City, CA and is listed as Nasdaq GILD. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Gilead Sciences; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
Approve Suite is not affiliated with Gilead Sciences. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.